Clinical Trial Update: Clinical Outcomes of Exenatide Versus Basal Insulin

View source ↗

Summary

The completed trial compared exenatide versus basal insulin in adults with type 2 diabetes to evaluate clinical outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Basal insulin (basal insulin)
• EXENATIDE (EXENATIDE)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Status: COMPLETED